La N-acetilcisteína reduce el progreso de daño cardíaco en modelos experimentales.
N-acetylcysteine is known in a number of medical specialties and its ability to decrease the impact of reperfusion injury in acute myocardial infarction has boosted its use in cardiology over the past decades. N-acetylcysteine has a farreaching range of effects since it functions as a protective age...
| Publicado en: | CorSalud Vol. 12; no. 2; pp. 214 - 219 |
|---|---|
| Autores principales: | , , |
| Formato: | Artículo |
| Publicado: |
Cardiocentro Ernesto Che Guevara
Apr-Jun2020
|
| Acceso en línea: | Ver este registro en EBSCOhost |